Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11919863 Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation

Patent 11919863 was granted and assigned to Bristol-Myers Squibb Company on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Bristol-Myers Squibb Company

Current Assignee

Bristol-Myers Squibb Company

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119198630

Patent Inventor Names

Maureen Kay Reilly0

Maksim Osipov0

Gregory Louis Beutner0

Mikhail Zibinsky0

Francisco Gonzalez-Bobes0

Adam Joseph Freitag0

Yu Fan0

Albert J. Delmonte0

...

Date of Patent

March 5, 2024

Patent Application Number

175529290

Date Filed

December 16, 2021

Patent Citations

‌

US Patent 9598422 Immunoregulatory agents

‌

US Patent 9643972 Immunoregulatory agents

Patent Primary Examiner

‌

Medhanit W Bahta

Patent abstract

The disclosure is directed to improved methods for preparing substituted quinolinylcyclohexylpropanamide compounds.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11919863 Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API